Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deep Rohan Chatterjee

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
RSC Medicinal Chemistry|September 23, 2024
Novel sulfonamides unveiled as potent anti-lung cancer agents <i>via</i> tumor pyruvate kinase M2 activationRudradip Das, Deep Rohan Chatterjee, Saumya Kapoor, et al.
Drug Discovery Today|November 25, 2025
Pyruvate kinase M2 - linked metabolic pathways in pain modulationVaishnavi Kalmegh, Lahanya Guha, Deep Rohan Chatterjee, et al.
Current Drug Targets|March 31, 2023
Roadmap to Pyruvate Kinase M2 Modulation - A Computational ChronicleSaumya Kapoor, Deep Rohan Chatterjee, Moumita Ghosh Chowdhury, et al.
Bioorganic Chemistry|December 18, 2024
Development of novel tetrazole-based pyruvate kinase M2 inhibitors targeting U87MG glioblastoma cellsMoumita Ghosh Chowdhury, Saumya Kapoor, Venkatesh Muthukumar, et al.
RSC Medicinal Chemistry|February 5, 2026
2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunitiesPranav Kumar Ambast, Saumya Kapoor, Rudradip Das, et al.
Drug Discovery Today|October 28, 2022
PROTACting the kinome with covalent warheadsDeep Rohan Chatterjee, Saumya Kapoor, Meenakshi Jain, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|June 6, 2025
IMID-284: a potent pyruvate kinase M2 inhibitor with dual anti-inflammatory and analgesic effects in intervertebral disc diseaseGyanoday Tripathi, Komal Bhombe, Deep Rohan Chatterjee, et al.
Drug Development Research|December 12, 2023
Comprehensive characterization and preclinical assessment of an imidazopyridine-based anticancer lead moleculeRatik Ramesh Bulbule, Tarang Jadav, Niraj Rajput, et al.
Bioorganic & Medicinal Chemistry|June 29, 2026
Coumarin-sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growthDeep Rohan Chatterjee, Gourav Choudhary, Shailendra Sharma, et al.
Chemico-Biological Interactions|July 27, 2025
Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosisMeenakshi Jain, Adil Ali Sayyed, Piyush Gondaliya, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
RSC Medicinal Chemistry|September 23, 2024
Novel sulfonamides unveiled as potent anti-lung cancer agents <i>via</i> tumor pyruvate kinase M2 activationRudradip Das, Deep Rohan Chatterjee, Saumya Kapoor, et al.
Drug Discovery Today|November 25, 2025
Pyruvate kinase M2 - linked metabolic pathways in pain modulationVaishnavi Kalmegh, Lahanya Guha, Deep Rohan Chatterjee, et al.
Current Drug Targets|March 31, 2023
Roadmap to Pyruvate Kinase M2 Modulation - A Computational ChronicleSaumya Kapoor, Deep Rohan Chatterjee, Moumita Ghosh Chowdhury, et al.
Bioorganic Chemistry|December 18, 2024
Development of novel tetrazole-based pyruvate kinase M2 inhibitors targeting U87MG glioblastoma cellsMoumita Ghosh Chowdhury, Saumya Kapoor, Venkatesh Muthukumar, et al.
RSC Medicinal Chemistry|February 5, 2026
2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunitiesPranav Kumar Ambast, Saumya Kapoor, Rudradip Das, et al.
Drug Discovery Today|October 28, 2022
PROTACting the kinome with covalent warheadsDeep Rohan Chatterjee, Saumya Kapoor, Meenakshi Jain, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|June 6, 2025
IMID-284: a potent pyruvate kinase M2 inhibitor with dual anti-inflammatory and analgesic effects in intervertebral disc diseaseGyanoday Tripathi, Komal Bhombe, Deep Rohan Chatterjee, et al.
Drug Development Research|December 12, 2023
Comprehensive characterization and preclinical assessment of an imidazopyridine-based anticancer lead moleculeRatik Ramesh Bulbule, Tarang Jadav, Niraj Rajput, et al.
Bioorganic & Medicinal Chemistry|June 29, 2026
Coumarin-sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growthDeep Rohan Chatterjee, Gourav Choudhary, Shailendra Sharma, et al.
Chemico-Biological Interactions|July 27, 2025
Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosisMeenakshi Jain, Adil Ali Sayyed, Piyush Gondaliya, et al.
Pageof 2